Anti-NGF treatments for pain — two steps forward, one step back?
Crossref DOI link: https://doi.org/10.1038/nrrheum.2016.224
Published Online: 2017-01-25
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lane, Nancy E.
Corr, Maripat
Text and Data Mining valid from 2017-01-25
Article History
First Online: 25 January 2017
Competing interests
: N.E.L. declares that she is a consultant to and advisory board member for Regeneron. M.C. declares no competing interests.